PS375 million Government funding for better treatment of neurodegenerative diseases.

People suffering from neurodegenerative diseases could live longer, healthier lives thanks to the latest new research, following the government’s commitment to invest PS375 million over the next 5 years.

At least PS50 million will be made available to research in order to find a cure for motor neurone disease (MND) A condition that affects the nerves and brains and affects thousands of people in the UK. New, innovative research projects will help researchers to better understand the disease and its related conditions, develop and test treatments and improve care for those living with MND.

The entire PS375 million investment will finance research projects in a variety of diseases, including Pick’s Disease, Frontotemporal dementia and Wernicke-korsakoff, as well as Parkinson’s Disease dementia. It will also help fund research into Alzheimer’s disease, Lewy Body dementia, Alzheimer’s mild cognitive impairment, and Lewy Body dementia. This will enhance our understanding and enable us to look for new therapies.

For MND, a new NIHR Research Unit will be set up to coordinate research proposals for the new funding, promoting more creative research with the ultimate goal of finding the cure.

The government has already invested millions of pounds into MND research, including more than PS7 million to support groundbreaking clinical trials that have led to major advancements in the way that the disease is comprehended. This includes a better understanding of how different types MND are passed down through genetics and could lead to new treatments for patients who are undergoing gene therapy.

Riluzole is a drug that slows the progress of MND and prolongs the life of a person, is currently the only approved drug in the UK. The funding announced today will speed up the process across the UK to discover better treatments for MND and will give those who suffer from the condition the chance to enjoy a higher quality of life, as well as more years of happiness with their loved family members.

Health and Social Care Secretary, Sajid Javid, said:

Neurodegenerative disorders like MND can be devastating to people’s lives. I’m committed to ensuring that the government is doing everything it can to fight these diseases and assist those affected.

We have already invested millions of dollars in MND research and treatment. Our new commitment to funding will fund more research into this and other neurodegenerative diseases.

The UK is a world-class leader in medical research. Our world-class research department was the key to the discovery of life-saving treatments for COVID-19, such as dexamethasone and Tocilizumab, and the development of the vaccine programme which has saved thousands of lives.

We will continue to make use of this innovation and expertise to support cutting-edge projects for better treatments for motor neurone patients, such as the amazing work being carried out at the NIHR Sheffield Biomedical Research Centre, where researchers are experimenting with new drugs to treat the condition.

Business Secretary Kwasi Kwarteng said:

The UK is home to some of the most transformative and innovative medical research in the world. the accessibility of this research funding, alongside the work of our robust life science and pharmaceuticals sectors, will make the most of this research to aid those suffering from motor neurone disease.

It is vital to increase our understanding of this condition in pursuit of new treatments and better care. I am happy to find UK institutions at the forefront of that work.”

The National Institute for Health Research (NIHR) has committed to ongoing research into MND, reinforced by issuing the Highlight Notice inviting applications from ambitious research projects to bring treatment options from the lab to the clinic as part of scaled-up efforts to improve the quality of medical care and support available.

The NIHR also granted a prestigious Research Professorship to Professor Chris McDermott, a leading motor neurone disorder researcher. The award will focus on improving the care of people who suffer from MND, bolstering the leadership in this field of research, and enhancing the development of clinical trials to ensure more people affected by the disease take part.

While there is much to be accomplished however, significant improvements have been made. This includes the development of better data sources such as MND Register and MND Biobanks that support researchers in their quest to better understand the disease.

Improved data sets make it easier for scientists to track responses to treatments in clinical trials. And through innovative and flexible trial designs, researchers are able to conduct trials that are faster and less expensive that could bring new treatments to patients faster.

As well as the funding for research into neurodegenerative diseases, a new motor neurone disease alliance will be established to pool expertise and resources across the research community to speed up the development of new treatments. The partnership, which is funded by PS4 million, is funded by the National Institute for Health Research, UK Research and Innovation, Life Arc, MND Association and My Name’5 Doddie Foundation.

Researchers can apply for funding via the NIHR and UKRI websites.

Content Source:

Gemma Wilson

Gemma is a journalism graduate with keen interest in covering business news – specifically startups. She has as a keen eye for technologies and has predicted quite a few successful startups over the last couple of years.

Related Articles